It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Some features of ATS will be disabled while you continue to use an ad-blocker.
The Therapeutic Goods Administration has been notified of two more fatal cases of the rare blood clotting disorder related to AstraZeneca.
One is a 44-year-old man from Tasmania, and the other a 48-year-old woman from Victoria, reported as a probable thrombosis with thrombocytopenia syndrome (TTS) case last week.
Tasmanian State Health Commander Kathrine Morgan-Wicks said the man was a confirmed case of TTS.
He was vaccinated in a Tasmanian state vaccination clinic.
Ms Morgan-Wicks said TTS was a rare but serious condition.
"TTS is thought to occur due to an immune response to the AstraZeneca vaccine and is different to other conditions," she said.
She said people should seek immediate medical attention if they developed symptoms such as "severe or persistent headaches, blurred vision, confusion or seizures, shortness of breath, chest pain, leg swelling or persistent abdominal pain".
Ms Morgan-Wicks said in people over the age of 60 the benefits of the AstraZeneca vaccine outweigh the rare risks associated with vaccination.
The man's death will be investigated by the coroner
More suspected vaccine blood clotting related deaths
Taking my chances with Covid,
originally posted by: djz3ro
a reply to: AtomicKangaroo
2 out of how many?
There have been 6.1 million doses of the AstraZeneca vaccine administered, and six deaths related to the first dose, the TGA has said. There have been 87 cases of TTS to date. Of the four previous deaths, three were cases of TTS and one was a case of immune thrombocytopenia (ITP).
originally posted by: MichiganSwampBuck
As far as the risk of vaccines vs COVID, you can avoid the risk of vaccines entirely by not taking it and if you go full blown Howard Hughes, you have a good chance of avoiding COVID exposure as well.